Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Acta Neurologica Scandinavica
|
July 16, 2003
Age, education and test performance on the Finnish CERAD
M Karrasch, M Laine
FEBS Letters
|
November 12, 1990
The molybdenum cofactor of formylmethanofuran dehydrogenase from Methanosarcina barkeri is a molybdopterin guanine dinucleotide
M Karrasch, G Börner, R K Thauer
FEBS Letters
|
September 23, 1991
Molybdopterin adenine dinucleotide and molybdopterin hypoxanthine dinucleotide in formylmethanofuran dehydrogenase from Methanobacterium thermoautotrophicum (Marburg)
G Börner, M Karrasch, R K Thauer
The Western Journal of Medicine
|
April 1, 1979
Ischemic heart disease. Precarious coronary lesions and prognosis
A A Kattus, A H Coulson, M Karrasch
Acta Neurologica Scandinavica
|
May 15, 2013
CERAD test performance and cognitive impairment in Parkinson's disease
M Karrasch, S Laatu, K Martikainen, et al.
Dementia and Geriatric Cognitive Disorders
|
March 15, 2013
Apathy is associated with activities of daily living ability in Parkinson's disease
S Laatu, M Karrasch, K Martikainen, et al.
FEBS Letters
|
August 14, 1989
Formylmethanofuran dehydrogenase from methanogenic bacteria, a molybdoenzyme
M Karrasch, G Börner, M Enssle, et al.
European Journal of Biochemistry
|
December 12, 1990
The molybdoenzyme formylmethanofuran dehydrogenase from Methanosarcina barkeri contains a pterin cofactor
M Karrasch, G Börner, M Enssle, et al.
Acta Neurologica Scandinavica
|
October 3, 2014
Education-corrected CERAD identifies MCI and dementia in Parkinson's disease
M Karrasch, S Laatu, U Ellfolk, et al.
Acta Neurologica Scandinavica
|
February 5, 2005
CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease
M Karrasch, E Sinervä, P Grönholm, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Acta Neurologica Scandinavica
|
July 16, 2003
Age, education and test performance on the Finnish CERAD
M Karrasch, M Laine
FEBS Letters
|
November 12, 1990
The molybdenum cofactor of formylmethanofuran dehydrogenase from Methanosarcina barkeri is a molybdopterin guanine dinucleotide
M Karrasch, G Börner, R K Thauer
FEBS Letters
|
September 23, 1991
Molybdopterin adenine dinucleotide and molybdopterin hypoxanthine dinucleotide in formylmethanofuran dehydrogenase from Methanobacterium thermoautotrophicum (Marburg)
G Börner, M Karrasch, R K Thauer
The Western Journal of Medicine
|
April 1, 1979
Ischemic heart disease. Precarious coronary lesions and prognosis
A A Kattus, A H Coulson, M Karrasch
Acta Neurologica Scandinavica
|
May 15, 2013
CERAD test performance and cognitive impairment in Parkinson's disease
M Karrasch, S Laatu, K Martikainen, et al.
Dementia and Geriatric Cognitive Disorders
|
March 15, 2013
Apathy is associated with activities of daily living ability in Parkinson's disease
S Laatu, M Karrasch, K Martikainen, et al.
FEBS Letters
|
August 14, 1989
Formylmethanofuran dehydrogenase from methanogenic bacteria, a molybdoenzyme
M Karrasch, G Börner, M Enssle, et al.
European Journal of Biochemistry
|
December 12, 1990
The molybdoenzyme formylmethanofuran dehydrogenase from Methanosarcina barkeri contains a pterin cofactor
M Karrasch, G Börner, M Enssle, et al.
Acta Neurologica Scandinavica
|
October 3, 2014
Education-corrected CERAD identifies MCI and dementia in Parkinson's disease
M Karrasch, S Laatu, U Ellfolk, et al.
Acta Neurologica Scandinavica
|
February 5, 2005
CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease
M Karrasch, E Sinervä, P Grönholm, et al.
Page
of 3